TSE:JWEL
25.24
0.04
(0.16%)
Founded in 1922, Jamieson is Canada's leading branded manufacturer, distributor and marketer of high quality natural health products.
More at Wikipedia
Analysis and Opinions about JWEL-T
Signal
Opinion
Expert
BUY
BUY
November 25, 2019
A fine IPO performer; they did a good job to ensure that private equity fund involved got cleaned out, so that overhang didn't happen. They just put out a strong report with good international growth. This may be added to an index. Not a cheap stock, but they boast earnings growth and a strong brand. He owns a lot of this.
A fine IPO performer; they did a good job to ensure that private equity fund involved got cleaned out, so that overhang didn't happen. They just put out a strong report with good international growth. This may be added to an index. Not a cheap stock, but they boast earnings growth and a strong brand. He owns a lot of this.
HOLD
HOLD
June 13, 2019
They did a good job of getting the private equity guys out of it so there was lots for individual investors. They are gearing up for a better second half.
They did a good job of getting the private equity guys out of it so there was lots for individual investors. They are gearing up for a better second half.
HOLD
HOLD
January 17, 2019
Vitamins and health supplements, protein supplements. They missed on earnings. It is a great Canadian company. A pickup in the cold and flu season would benefit them. They are trying to penetrate the Chinese market. They Manufacture in Winsor and Scarborough.
Vitamins and health supplements, protein supplements. They missed on earnings. It is a great Canadian company. A pickup in the cold and flu season would benefit them. They are trying to penetrate the Chinese market. They Manufacture in Winsor and Scarborough.
WATCH
WATCH
November 19, 2018
A stable, high-quality business. When it IPO'd, the market over-rewarded it, but the stock has since corrected to something attractive. The healthy trend works for them. he's studying it.
A stable, high-quality business. When it IPO'd, the market over-rewarded it, but the stock has since corrected to something attractive. The healthy trend works for them. he's studying it.
HOLD
HOLD
October 17, 2018
He likes the trend towards health and wellness through supplements and protein shakes. The company has been given a license to sell their branded product in China. His fund will continue to hold this stock.
He likes the trend towards health and wellness through supplements and protein shakes. The company has been given a license to sell their branded product in China. His fund will continue to hold this stock.
PAST TOP PICK
PAST TOP PICK
September 20, 2018
(A Top Pick July 20/17, Up 56%) He looks for companies that dominate their market. This is the number one consumer healthcare brand. More than the next 5 largest competitors combined. It was a show-me story at the time. It needs to penetrate other geographical markets like China for continued growth. It is fairly valued at this price.
(A Top Pick July 20/17, Up 56%) He looks for companies that dominate their market. This is the number one consumer healthcare brand. More than the next 5 largest competitors combined. It was a show-me story at the time. It needs to penetrate other geographical markets like China for continued growth. It is fairly valued at this price.
COMMENT
COMMENT
March 8, 2018
Smaller cap than she would buy. Vitamin manufacturer and retailer. A good one to own.
Smaller cap than she would buy. Vitamin manufacturer and retailer. A good one to own.
TOP PICK
TOP PICK
December 12, 2017
It is the most prominent name in wellness and vitamins. This company is becoming globally entrenched, but it is very Canadian. It will carry on growing. It has had great numbers. They are at the low end of the price range as holistic people would be willing to pay three times more for the pills. He thinks it has growth potential. (Analysts’ target: $22.25).
It is the most prominent name in wellness and vitamins. This company is becoming globally entrenched, but it is very Canadian. It will carry on growing. It has had great numbers. They are at the low end of the price range as holistic people would be willing to pay three times more for the pills. He thinks it has growth potential. (Analysts’ target: $22.25).
TOP PICK
TOP PICK
July 20, 2017
It is the MacDonald’s of the vitamin business. It is the number one Canadian consumer health brand. They have more market share than their 5 biggest peers combined. They have exposure in China. He thinks it will be a success-IPO story like DOL-T. It is now going to be a show-me story as they grow their top line.
It is the MacDonald’s of the vitamin business. It is the number one Canadian consumer health brand. They have more market share than their 5 biggest peers combined. They have exposure in China. He thinks it will be a success-IPO story like DOL-T. It is now going to be a show-me story as they grow their top line.
Showing 1 to 9
of 9 entries
- «
- ‹
- 1
- ›
- »
© Stockchase Inc.
9
